Endonovo Therapeutics Hires David Clark as Vice President of Sales
May 03, 2019 09:20 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, May 03, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced veteran sales leader David Clark joined as Endonovo’s Vice President of Sales. In his new...
Endonovo Therapeutics Hires Nevena Zubcevik of Harvard Medical School as Chief Medical Officer
May 02, 2019 09:20 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, May 02, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced the appointment of Nevena Zubcevik, DO, MSPT, ATC as its chief medical officer starting...
Endonovo Therapeutics Provides Corporate Update
April 26, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, April 26, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Announces Partnership with Second Hospital
March 29, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA , March 29, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced an agreement with a nationally recognized hospital group...
Endonovo Therapeutics Granted Trademarks for WoundPulse and OrthoHalo
March 22, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 22, 2019 (GLOBE NEWSWIRE) -- March 22, 2019 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Endonovo Therapeutics Partners with SunMED Medical Systems
March 20, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 20, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), Alan Collier, Endonovo’s Chief Executive Officer, stated "We are...
Endonovo Therapeutics Announces New Website Launch
February 27, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
The completely redesigned website offers visitors deeper insight into the Company's core product, SofPulse® LOS ANGELES, CA, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:...
Endonovo Therapeutics Files Lawsuit against KVP International Inc., Orthocor Medical Inc., and Careus Corp. for Patent Infringement
February 08, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Issues Shareholder Letter and Update
January 11, 2019 09:15 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Enters into $10 million Common Stock Purchase Agreement with Azure Capital
January 03, 2019 11:10 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...